ASK REDCHAT ANYTHING ABOUT SOL-GEL TECHNOLOGIES LTD.
Sol-Gel Technologies Ltd. (NASDAQ: SLGL)
Listen to this Section
$74.19
+0.7910
(
+1.08% )
13.1K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| EPSOLAY® (benzoyl peroxide) CreamDetailsPapulopustular Rosacea |
Approved |
| TWYNEO® (benzoyl peroxide and tretinoin) Cream, 3%/0.1%DetailsAcne Vulgaris |
Approved |
| SGT-610 (Patidegib)DetailsGorlin Syndrome, Basal cell carcinoma |
Phase 3 |
Market Data
|
| Open |
$74.19 |
| Previous Close |
$73.40 |
| Volume |
13.1K |
| Market Cap |
$239.94M |
| Day Range |
$73.03 - $76.88 |
| 52 Week Range |
$6.96 - $97.97 |
| Shares Outstanding |
3.27M |
| Change % |
+1.08% |
| Net Change |
▲ 0.7910 |
| Insider Ownership |
N/A |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2018 |
| Country | Israel |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
0.00
| Date |
Type |
Amount Purchased |
Purchaser |
| No records found. |